NCT05491291

Brief Summary

Chronic wound of lower limb. In developed countries, the prevalence of chronic wounds is linked to the ageing of the population and the increase in chronic diseases such as diabetes, obesity and cardiovascular disease. Consequence: amputations of lower limb. The prevalence of chronic wounds is also variable across the globe. In addition, chronic wounds are associated with psychosocial problems such as poor quality of life, loss of professional activity and progressive de-socialization of patients. To improve the quality of care we need in french wound assessment tools validated scientifically like the RESVECH 2.0 scale, validated in the Spanish language.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 8, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 8, 2022

Status Verified

August 1, 2022

Enrollment Period

1.5 years

First QC Date

August 4, 2022

Last Update Submit

August 4, 2022

Conditions

Keywords

Chronic woundsRESVECH 2.0Wound assesment toolcross-cultural validation,

Outcome Measures

Primary Outcomes (2)

  • Cultural adaptation of the RESVECH 2.0 scale.

    Validation of scale RESVECH 2.0 translation in french language depending on the cultural context in French West Indies

    Before the start of recruitment

  • Psychometric validation of the RESVECH 2.0 scale.

    Scientific validation of the french version of the scale RESVECH 2.0 in French West Indies

    15 days post inclusion

Study Arms (1)

Patients with chronic wound of the lower limbs

OTHER

Passing of the scale when the patient will come at the hospital for his routine health care visit in M@diCICAT center

Other: Patients with chronic wound of the lower limbs

Interventions

The rating scale will be passed at three different times, day 1, day 15 and day 75.

Patients with chronic wound of the lower limbs

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with at least one chronic wound of the lower limbs admitted to the M@diCICAT® healing centre.
  • Patients agreeing to participate in the study
  • Patients affiliated to a social security scheme

You may not qualify if:

  • Patients with critical ischemia of the lower limb concerned
  • Patients under legal protection measures (guardianship, curatorship, safeguard of justice) and persons deprived of liberty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Martinique

Fort-de-France, 97261, Martinique

Location

Related Publications (2)

  • Alvarez-Del-Rio RF. Factors Associated to the Cicatrization Success of Lower-Limb Ulcer of Venous Etiology. Invest Educ Enferm. 2018 Sep;36(3). doi: 10.17533/udea.iee.v36n3e08.

  • Aragon-Sanchez J, Lipsky BA, Lazaro-Martinez JL. Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients? Diabet Med. 2011 Feb;28(2):191-4. doi: 10.1111/j.1464-5491.2010.03150.x.

Related Links

Study Officials

  • Maria CANO SANCHEZ, RN

    CHU de Martinique

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The rating scale will be passed at three different times, day 1, day 15 and day 75.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2022

First Posted

August 8, 2022

Study Start

November 1, 2022

Primary Completion

May 1, 2024

Study Completion

August 1, 2024

Last Updated

August 8, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations